Article Text

Download PDFPDF

‘Implementability’ matters: using implementation research steps to guide and support non-communicable disease national planning in low-income and middle-income countries
  1. Angela Mary Jackson-Morris1,
  2. Gerald Mutungi2,
  3. Ephantus Maree3,
  4. Temo Waqanivalu4,
  5. Robert Marten5,
  6. Rachel Nugent1
  1. 1Center for Global Noncommunicable Diseases, RTI International, Durham, North Carolina, USA
  2. 2Noncommunicable Diseases, Republic of Uganda Ministry of Health, Kampala, Uganda
  3. 3Noncommunicable Diseases, Kenya Ministry of Health, Nairobi, Kenya
  4. 4Department of Non-communicable Diseases, World Health Organisation, Suva, Fiji
  5. 5WHO Alliance for Health Policy and Systems Research, Geneva, Switzerland
  1. Correspondence to Dr Angela Mary Jackson-Morris; ajackson-morris{at}


The ‘implementation gap’ between national plans and successful implementation is a central theme in addressing non-communicable diseases (NCDs). It is a factor that has undermined Sustainable Development Goal 3.4, which aims to achieve a one-third reduction in premature mortality from four major NCDs by 2030. Responding to the potential of implementation research to support low-income and middle-income countries to effectively advance their strategies, we describe ways to make NCD plans more robust by including implementation steps. These steps are (1) choosing some (but not all) effective and cost-effective options; (2) tailoring interventions and their scale-up to national capacity; and (3) making the priorities implementable. We illustrate with examples from several countries.

  • Health policy

Data availability statement

All data relevant to the study are included in the article.

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See:

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Summary box

  • Progress to implement effective solutions to non-communicable diseases in low- and middle- income countries varies; and for progress to accelerate more widely, it is essential to understand what currently undermines implementation.

  • Implementation research has been identified as a means to address the NCD ‘implementation gap’, yet application has been limited, and examples relate to specific, isolated aspects of implementation.

  • This paper presents a model that links analyses that address specific aspects of implementation into a coherent step-by-step process, illustrated with examples from various countries, and highlights where national capacity needs to be strengthened.


Achieving Sustainable Development Goal (SDG) 3.4 to reduce premature mortality from non-communicable diseases (NCDs) is in jeopardy and is most threatened in low-income and middle- income countries, where NCDs are already 7 in 10 deaths.1 Progress in implementing effective solutions varies. For progress to accelerate, it is paramount to understand what undermines implementation.2 The ‘implementation gap’ is often discussed as if it were an end-stage issue—that is, countries somehow fail to successfully implement strong plans.

Rather than this final implementation stage being the problem, we suggest there are critical upstream issues. The value of implementation research has been recognised and applied with strong results for other health needs. It has been advocated as a means to better address NCDs,3 yet application has been limited. To realise this potential,4 coauthors drew from their experience, developing and leading national implementation plans and undertaking implementation research. Our aim was to create a coherent step-by-step process using specific implementation analyses and highlighting capacity gaps to create stronger NCD plans. We drew from our earlier NCD implementation roadmap,5 the WHO Multisectoral Action Plan (MAP) toolkit6 and the experiences of several countries.

The WHO has developed policy intervention recommendations for addressing NCDs, including the ‘Best Buys’7 for cost-effectiveness, PEN (Package of Essential Noncommunicable Disease Interventions) for primary care,8 MPOWER (Monitor, Protect, Offer, Warn, Enforce and Raise) for tobacco,9 SHAKE (Surveillance, Harness, Adopt, Knowledge and Environment) for salt,10 and SAFER (Strengthen, Advance, Facilitate, Enforce and Raise) for alcohol.11 Countries select policies that will be most impactful and cost-effective in their economic, social and institutional context, taking account of their capacity and needs. This requires assessing what is needed to put interventions into practice, identifying potential obstacles, and using this information to tailor intervention design and create supporting measures. The terms feasibility and viability have sometimes been used12; however, we use ‘implementability’ for its stronger link to successful implementation rather than its theoretical possibility, also encompassing the concept of ‘readiness’.13

We describe a practical process to guide countries to create more implementable NCD plans. We elaborate one possible model to explain and illustrate how implementation research can provide stakeholders with the data and insights they require. The steps are presented as sequential but their application need not be. Countries can simultaneously build on progress while identifying weaknesses and ways to address these. Countries face unique challenges relating to their context, but the proposed process focuses on addressing important common challenges undermining implementation. Developing national and local implementation research capacity is key, as this not only enables application of the ‘standard’ steps set out in this paper, but also empowers stakeholders to find solutions to any context-specific challenges.

The process and supporting analyses are set out in figure 1.

Figure 1

Steps for strengthening the implementability of national plans. NCD, non-communicable disease.

Step 1: choosing effective and cost-effective options

Step 1 entails an investment case, although other names are used.14 Investment cases contribute to prioritisation of cost-effective interventions and are feasible for the context. Investment cases raise political awareness of the costs of inaction, quantify the health and economic returns from investing, and demonstrate their contribution to SDG targets. They also can catalyse discussions about prioritising NCDs within national plans and budgets.15

Armenia’s investment case for NCDs led to parliamentary discussions to pass a 2020 tobacco control law.16 The Jamaica NCD investment case supported the prime minister’s declared economic growth targets demonstrating economic benefits from reducing NCD risks.17 Both examples fed into existing policy processes and were used by stakeholders to advance their goals. An NCD investment case for Peru Ministry of Health (MOH) found policy packages targeting NCD risk factors, particularly salt and alcohol consumption, had higher health and economic returns than treatment choices. The Peru NCD investment case identified hypertension screening and early treatment initiation as having a high return in lives saved, healthy life years gained and economic savings.18

Historically healthcare services predominated priority-setting discussions, with primary and secondary prevention relegated to a minor role, failing to reflect their critical importance. This might be because there is a powerful and vocal constituency for increased health services, including people living with diseases. Applying an analytical process enables a more even-handed consideration of a broader set of options to identify which will deliver the strongest health and economic benefits for a country. These may be in the policy domain as in the aforementioned examples or derive from preventive interventions delivered by the health system. The critical need to invest in prevention as well as treatment was apparent to Kenya MOH after an initial analysis identified a weak return on investment for cancer treatment in the short-medium term.19 For example, with support from the World Bank in Kenya, RTI International analysed preventive interventions for two highly prevalent cancers. The new analysis demonstrated that the benefits of early detection and treatment outweigh the costs in the long run, recommending scale-up of human papillomavirus vaccination and clinician and population awareness initiatives to improve early breast cancer diagnosis.20

To initiate a discussion about greater resource needs for NCD prevention and control, the Uganda MOH requested the United Nations Inter-Agency Task Force on NCDs (UNIATF) to develop evidence-based arguments. With stakeholder input and review of national data and documents, the Uganda investment case provided return on investment for detailed health service scale-up scenarios.21 The investment case has helped policymakers become aware that population health can provide long-term benefits and is being used to mobilise resources.

The United Nations Development Programme and UNIATF have responded to more than 50 country requests for investment cases since 2016. Meanwhile, advances in analytical methods are underway to improve the country-level data used, adhere to best practice recommendations for economic evaluations, and display and disseminate results to capture media and policy audience attention.22 A UNIATF meeting in April 2021 to share investment case methods strongly recommended framing investment cases as priority-setting exercises.23 It also highlighted how investment cases have been used as learning tools to identify weaknesses, gaps and opportunities. It was further noted that their results can gain wider traction when the sponsoring NCD division has links and relationships within and beyond the MOH, enabling it to leverage investment case results to achieve change beyond their division’s own purview.

Data relating to disease prevalence, programme coverage, costs and intervention effectiveness play a central role within these analyses, yet it is the case that NCD data, health information systems (HIS) more generally, and monitoring and evaluation in many low-income and middle-income countries (LMICs) are weak.24 Credibility is improved when locally produced data are used, underlining the critical need for countries to strengthen NCD surveillance systems—for example, undertaking STEPS (WHO STEPwise Approach to NCD Risk Factor Surveillance) surveys—and extend HIS to incorporate NCDs where this is not yet the case, supported by staff and infrastructure capacity development. National, system-wide HIS developments have been achieved in various countries but NCDs have frequently been excluded, resulting in fragmented and weak data. Given that NCD prevalence now exceeds that of many other health needs across LMICs, strengthening and mainstreaming NCD data need to be a domestic and donor priority.

Step 2: tailoring to national capacities

Even prioritised interventions may remain unimplemented unless they are grounded in national health system capacity and that of wider sectors that play essential roles for prevention policies.25 In step 2, national capacities and readiness to scale and integrate interventions are assessed. Participatory implementation research with stakeholders can be used to make such assessments and identify existing capacities including workforce skillset, infrastructure and systems, and community reach, as well as areas requiring capacity building.

Global analysis indicates various gaps in the infrastructure required to deliver NCD interventions in LMICs, such as workforce training, access to essential medicines, equipment and technology, guidelines and protocols, and laboratory services.26 In contrast, country-level needs assessments must be highly specific to what is needed to put national priority NCD interventions into practice. Undertaking a capacity assessment highlights areas where sufficient capacities exist to support implementation and specific gaps that need to be addressed—and this evidence of specific need can enable resource allocation (domestic or donor) to fill the gap. The WHO Service Availability and Readiness Assessment (SARA) is a tool to assess capacity across different health services27 and the WHO-PEN for primary healthcare in low-resource settings8 enables detailed health service assessment specifically for NCDs. For example, the Ugandan MOH Programme for the Prevention and Control of NCDs and the Uganda Initiative for Integrated Management of NCDs applied PEN to conduct the first national assessment of the readiness of public sector health facilities to provide NCD services. This identified areas of strength and gaps and weaknesses at specific levels and need to address availability of NCD-specific equipment, medicines, laboratory tests and in the workforce. The assessment also pinpointed weaknesses in basic screening and prevention services and the need for greater emphasis on quality assurance and monitoring.28

In contrast, the 2008 Tanzanian National NCD Strategy did not include or draw on capacity and readiness assessment,29 whereas subsequent assessments identified important gaps and weaknesses to explain the plan’s limited effectiveness. Tanzania’s 2016 National NCD Strategy explicitly included situational analysis using the SARA tool and could thereby articulate more detailed policy priorities and implementation activities.30 The lesson is that steps to determine exactly what capabilities are needed and where—in the health system, ministries or wider parts of government, and in civil society—should precede implementation.

Addressing NCDs requires greater priority for health promotion and prevention and these will be identified at step 1 as some of the most effective and cost-effective options. Capacity assessment for these is therefore important. These policies have been highlighted in various global reports and guidance as central,7 and often require involvement and sometimes the leadership of non-health sectors and partnerships across and beyond the government. The SARA assessment focuses on health system interventions; however, the national prevention policy and community actions that take place beyond the health system need to be assessed. Broadening capacity assessment to other sectors, including existing cross-sectoral policies, is important to identify gaps that would undermine what on paper may appear to be a strategic and strong NCD intervention and enable adequate planning and resourcing.31 Multistakeholder coordination mechanisms are a proven means to facilitate such engagement for various health conditions, being notably well developed for HIV-AIDS.32 While some cross-sectoral mechanisms have existed for many years—in Bangladesh for instance—more countries are developing NCD cross-sectoral groups and these may be used to assess the wider capacities available to support NCD prevention policies, strengthening requirements, and to identify barriers and how the strategy should address these. Review of the Tonga National NCD Strategy 2010–2015 found that critical governance and infrastructure gaps were impeding the implementation of NCD prevention and control strategies. As a result, in 2014, a national NCD committee with cross-government membership began to coordinate national NCD planning.33

Step 3: making the plans and priorities implementable

The next step involves a set of enabling processes, detailed below, that can make the difference between an NCD plan being only ‘a document on a shelf’ or being an implemented plan. Specific analyses can define and put in place these enabling processes aligned with national circumstances, opportunities and constraints.


Costing a national plan or strategy is an implementation prerequisite, not only to assess what is affordable but more fundamentally to ensure the required resources for NCDs are allocated within the national health budget. Lack of costing for national NCD plans has been reported as a contributory factor for non-implementation in high-income countries34 and LMICs.35 The situation is improving, however, as global NCD service cost estimates have recently become available36 and more countries have costed NCD strategies.36 Capacity building for local health economists and budget specialists has enabled health ministries to participate in the all-important government budgeting cycle,37 and those responsible for NCD strategy implementation need to be involved.38

Costing exercises reinforce the idea that providing a package of NCD services can be costly. Watkins et al35 report that 25%–34% of costs for the high-priority health intervention package in lower-income and lower-middle-income countries, respectively, would be required to fund 27 priority NCD interventions.35 Yet, without a realistic cost assessment for meeting NCD needs, ministries and stakeholders cannot request and advocate for (more) appropriate allocations. Moreover, rigorous costing for a package of priority NCD services can highlight potential savings by showing where prices can be reduced (eg, medicines) and cost efficiencies may be achieved (eg, integrating service delivery for comorbidities). The US Centers for Disease Control (CDC) developed a costing tool to accompany the WHO Global HEARTS technical package that has been used in various countries to assess NCD service costs.39

In 2021 the Government of Kenya launched its new Strategic Plan for the Prevention and Control of NCDs (2021–2025).40 Based on previous experience, whereby implementation of the preceding NCD strategy had been hampered by an absence of detailed costing, a costing analysis was undertaken to assist the development of realistic annual budgets to support the new plan. Activity-based costing was used to allocate input costs for activities where data existed and identify drivers of potential cost changes. The WHO One Health Tool was used to generate estimates for NCD commodity costs where forecasting and quantification data were lacking, alongside a pilot NCD Forecasting Tool for hypertension and diabetes medicines and technologies.

Financing options

Strong plans require adequate resources to put them into practice. Currently the financial resources available for NCD implementation are inadequate relative to the scale of burden and the capacity development required in many systems.41 Increasing domestic budgetary allocations to NCDs is needed, yet the COVID-19 pandemic hit the Gross Domestic Product (GDPs) of African countries especially hard. This situation calls for international donors and multilaterals to step up to address current NCD needs, to help countries strive to meet SDG 3.4 and to achieve long-term savings from slowing the onset of NCDs. Increasing national NCD resourcing is also vital to reduce the inordinate proportion of patient household income currently spent on out-of-pocket healthcare fees.

The necessary complement to costing NCD implementation is to identify the most appropriate financing options. Funding for NCDs will not be considered in isolation but as part of overall health system funding, and is best supported by good costing, priority-setting and budget planning within the MOH process. MOH NCD divisions can engage more strongly in financing dialogues after having assessed current and future needs and the funding gap. Thus, the ability to generate additional NCD financing within the domestic budget depends on the NCD unit having adequate information to justify requests. Ethiopia is an example of using strengthened domestic economic and budgeting capacity to bring about a robust discussion of NCD needs, resulting in significant scale-up of NCD services.36

Most LMIC NCD funding comes from domestic resources and NCD demand on domestic budgets will grow. An increased NCD budget will be more achievable if the economy is growing and there is willingness to allow increases in the total health budget. Other prerequisites are assuring value for money of implemented programmes and meeting equity goals. Assessment of financing options can explore the potential for additional revenue from, for example, resource reallocation, increased taxation, and innovative sources such as development bonds or social investment partnerships. Some countries, for instance Thailand and Philippines, have raised impressive revenues from taxing NCD-causing excisable products, such as alcohol, tobacco, unhealthy food and beverages, and fossil fuels, yet this strategy is generally underutilised.42

Innovative financing for NCDs is often touted as the solution to the financing gap.43 Social impact bonds (SIBs) are an innovative financing tool with seeming relevance to NCDs; however, a recent review found no LMIC examples of SIBs providing significant support for NCD programmes, and few high-income country examples had achieved their targets, suggesting that more experience is needed before SIBs will be a significant NCD funding contributor.44 In 2015, the WHO Global Coordination Mechanism Working Group provided recommendations for improving NCD financing and provided a template to help countries assess needs and options.45 The WHO is now developing a more detailed tool to guide NCD divisions, finance and budget officials in measuring the NCD financing gap and identifying options for reducing it.

Assessing integration options

Integration of NCDs into other health systems and services has been advocated as a potential means to address national capacity gaps and progress action.46 There is emerging evidence that this can also improve value for money.47 Step 3 includes assessing the scope and readiness for integrating NCDs within a country’s health system and programmes and drawing on existing capacities and infrastructure. Integration can be understood in different ways: co-located services providing more coordinated, user-centric care; and integration to achieve continuity of care over time, such as a child health package including antenatal, postnatal, newborn and young child services. Financing, budgeting, policymaking, management and even cross-sectoral collaboration can be considered integrated when simultaneously addressing multiple diseases and health goals.48

Many countries are currently testing integration options and identifying what type of integration may be most useful and how best to implement this. Integration of NCD care with HIV services is the programme area that has been tested to the greatest extent so far, and many countries have paired tuberculosis and diabetes care.49 Draft WHO guidance identifies health system readiness as an influential factor for successful integration, with certain levels of integration being suitable for different countries based on overall health system development. It identifies six assessment questions to assess readiness and strengths for NCD integration in primary healthcare, including governance, finance, human resources, service delivery, medicines and technology, and health information.46

In Uganda, the increased longevity of people living with HIV and the consequent growing burden of chronic disease in this population provided impetus to develop an NCD integration strategy in HIV care and other major vertical health programmes such as tuberculosis and maternal health. To better understand primary healthcare facilities’ capacity to manage NCDs, a needs assessment was undertaken helping the ministry understand gaps and mobilise resources to fill these. Integration pilot projects have been developed across different facility levels and regions to test diabetes and hypertension care delivery among these patient groups, and have generated evidence of patient and system benefit and learning related to integration planning.50 51 Training materials and NCD recording tools have been developed, alongside health worker training in NCD management. Supervision reports suggest increased screening and treatment initiation in regions where training has taken place.

Implementation planning

Steps 2 and 3 recommend specific analyses to address common NCD implementation pitfalls and strengthen national NCD planning. Nonetheless, there remains potential for strategies to be ineffective and poorly implemented if the ‘nuts and bolts’ of implementation planning, such as timelines, targets, monitoring and evaluation indicators, and assignment of delivery responsibility, are neglected52—something that is the case in high-income countries as well as LMICs.34 The WHO MAP toolkit includes a checklist highlighting these considerations.6 Moreover, LMIC governments and health ministries possess planning expertise, and this existing internal capacity may be leveraged to support stronger NCD implementation planning.53 54

Political will

Political will and leadership are essential for effective NCD policies to be passed and implemented.55 Even after addressing key information and planning gaps, an NCD strategy may still be unimplementable if political will and leadership are lacking. Our model does not address how to build and maintain political will. Nonetheless, the steps we have detailed can indirectly strengthen political will, first at step 1 by identifying the options most likely to provide health and economic gains enhancing their political attractiveness. The data can further strengthen buy-in when it is used for public advocacy, allowing politicians to appreciate public support for policies. Additionally, steps 2 and 3 enable a realistic assessment of what is possible and what needs to be done to make implementation effective, thus addressing the need for politicians to know that a strategy is implementable if they are to commit support.


Our evidence derives from analyses focused on the individual steps, which we propose may instead be considered components of an overarching process that can generate practical information to address specific gaps and strengthen national NCD plan implementability. Our contention is that ‘the whole is greater than the sum of its parts’, and countries can benefit by addressing important weak points as a linked process rather than in isolation. Some countries have undertaken components of our model; however, we are unaware of the full process being applied. Research should therefore be undertaken to assess application of the model, evaluate outcomes and understand how the analyses may work best within a nationally led process.


A majority of LMICs face a future in which the burden of NCDs on health systems and economies is a reality. Dealing with that burden is widely acknowledged to be the responsibility of ministries of health with cross-sectoral support from various other ministries. Ministries are actively seeking tools and guidance to make progress against the rise of NCDs, but the danger of failing to attain SDG 3.4 is palpable, even had COVID-19 not further spotlighted the additional vulnerability of people with NCDs.56 The NCD literature is awash with calls for governments to ‘act on NCDs’. Rather than non-implementation representing simply a ‘lack of political will’, we suggest it also relates to weaknesses in the process of developing NCD strategies and plans. Indeed, these processes can help foster political will.

The steps described can be used by countries to set a direction and timetable for delivering. We suggest that a joined-up process using the kind of analyses presented can help countries identify how to strengthen their NCD strategies, implementation plans and processes. The COVID-19 pandemic impacted and continues to impact health systems and NCD implementation in various ways, both positive and negative.57 The process outlined provides an opportunity to understand and design responsive NCD plans. In parallel to the tools and technical guidance now available on specific NCD issues, tools are also needed to help countries undertake the more specific types of analysis. Alongside the tools, however, as NCD national-level planning in many LMICs is still relatively new, support during initial planning cycles combined with capacity building will help build confidence and capacity while contributing to stronger implementation in the immediate term. In this way countries can move closer to closing their NCD ‘implementation gap’ and achieve the kind of progress that their national NCD strategies promise.

Data availability statement

All data relevant to the study are included in the article.

Ethics statements

Patient consent for publication



  • Handling editor Seye Abimbola

  • Twitter @angiembjm, @martenrobert, @rachelnugent

  • Contributors All authors contributed to discussion and writing of the manuscript. AMJ-M developed the concept in discussion with RN, and then expanded this further in discussion with RM, GM and EM.

  • Funding RTI International provided publication fees.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.